Ten portions of tomatoes per week decreases risk of prostate cancer
the ONA take:
According to a new study published in the journal Cancer Epidemiology, Biomarkers and Prevention, researchers at the Universities of Bristol, Cambridge, and Oxford in the United Kingdom have found that consuming 10 portions of tomatoes per week can reduce a person's risk for developing prostate cancer by 18%.
For the study, the researchers identified 1,806 men with prostate cancer and 12,005 men without cancer. Researchers compared the diets of the two group and found an association between consuming more selenium, calcium, and lycopene and a decreased risk for developing prostate cancer. Lycopene was found to have the largest benefits.
Lycopene is known to eliminate oxygenated free radicals and can destroy about 10 times more oxygenated free radicals than vitamin E. Tomatoes have the highest concentration of lycopene, but apricots, guava, papaya, pink grapefruit, and watermelon contain lycopene as well. Tomatoes also become a better source of lycopene when they are heated up, as the body has a difficult time extracting lycopene from raw tomatoes.
According to the American Cancer Society, about 1 in 7 men will be diagnosed with prostate cancer in his lifetime, and 1 in 36 will from the disease.
Consuming 10 portions of tomatoes a week can reduce risk for developing prostate cancer by 18%.
When it comes to staying prostate-cancer free, there's nothing like a routine checkup at the doctor's office ... or, easier yet, some tomatoes. It turns out that putting away 10 portions of the not-a-vegetable a week can lower your risk of developing prostate cancer by 18 percent, according to new research published in Cancer Epidemiology, Biomarkers and Prevention.
For the study, researchers at the Universities of Bristol, Cambridge, and Oxford compared the diets of 1,806 men with prostate cancer with those of 12,005 cancer-free men. They found that while consuming more selenium, calcium, and lycopene were all linked to a reduced risk of prostate cancer, lycopene— an antioxidant that gives tomatoes their bright-red hue— came with the biggest benefits.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
- Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|